Karius Test Gets Breakthrough Device Designation for Infectious Disease Diagnosis
The Karius Test, a diagnostic tool for lung infections in immunocompromised patients, received Breakthrough Device Designation from the FDA.
Read MorePosted by Andy Lundin | May 20, 2024 | Infectious Diseases |
The Karius Test, a diagnostic tool for lung infections in immunocompromised patients, received Breakthrough Device Designation from the FDA.
Read MorePosted by Chris Wolski | Nov 16, 2023 | Diagnostic Technologies |
Consolidation, legislation, new testing types, and a shift to more consumer-driven testing are some clinical laboratory predictions for 2024.
Read MorePosted by Andy Lundin | Nov 7, 2023 | Company News, Molecular Diagnostics |
Veracyte and Illumina will develop high-performing molecular tests as decentralized IVD tests on Illumina’s NextSeq 550Dx NGS instrument.
Read MorePosted by Andy Lundin | Sep 8, 2023 | Transfusion & Transplantation Tests |
Researchers have developed an electronic device for continuously monitoring the health of transplanted organs in real-time.
Read MorePosted by Chris Wolski | Aug 21, 2023 | Gastrointestinal Infections |
Diagnostic tests for an H. pylori infection can be invasive or noninvasive. Noninvasive testing is more cost-effective.
Read More